Basit öğe kaydını göster

dc.contributor.authorKarabela, Semsi Nur
dc.contributor.authorGedikbasi, Asuman
dc.contributor.authorIsiksacan, Nilgun
dc.contributor.authorOrdekci, Seyhan
dc.contributor.authorGunver, Mehmet Guven
dc.contributor.authorNeijmann, Sebnem Tekin
dc.contributor.authorKural, Alev
dc.date.accessioned2022-07-04T15:11:36Z
dc.date.available2022-07-04T15:11:36Z
dc.identifier.citationNeijmann S. T. , Kural A., Isiksacan N., Karabela S. N. , Ordekci S., Gunver M. G. , Gedikbasi A., "ANTIPHOSPHOLIPID ANTIBODY (aPL) PRESENCE IN COVID-19 PATIENTS", JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2022
dc.identifier.issn1305-6441
dc.identifier.othervv_1032021
dc.identifier.otherav_a24077a3-a5e3-4b0a-a056-e9278f69d37d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/184020
dc.identifier.urihttps://avesis.istanbul.edu.tr/api/publication/a24077a3-a5e3-4b0a-a056-e9278f69d37d/file
dc.identifier.urihttps://doi.org/10.26650/iuitfd.1059659
dc.description.abstractObjective: In our study, we aimed to show whether there is a relationship between antiphospholipid antibody (aPL) positivity and complications of COVID-19.
dc.language.isoeng
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectHealth Sciences
dc.subjectFamily Practice
dc.subjectFundamentals and Skills
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.subjectTemel Tıp Bilimleri
dc.titleANTIPHOSPHOLIPID ANTIBODY (aPL) PRESENCE IN COVID-19 PATIENTS
dc.typeMakale
dc.relation.journalJOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI
dc.contributor.departmentHeath Sci Univ , ,
dc.contributor.firstauthorID3425360


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster